Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product

Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double‐blind Study in Healthy Subjects

(2023) Vincent Chow et al.   Clinical Pharmacology in Drug Development

A Data Driven Approach to Support Tailored Clinical Programs for Biosimilar Monoclonal Antibodies

(2022) Elena Guillen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

(2020) HoUng Kim et al.   DRUGS

Investigation of antibody disulfide reduction and re-oxidation and impact to biological activities

(2015) Tian Wang et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases

(2015) Michele W L Teng et al.   NATURE MEDICINE

Monoclonal antibody disulfide reduction during manufacturing

(2013) Katariina M. Hutterer et al.   mAbs

Biosimilars in 3D

(2013) Ivo Abraham et al.   Bioengineered

Discovery and mechanism of ustekinumab

(2012) Jacqueline M. Benson et al.   mAbs

Applications of circular dichroism (CD) for structural analysis of proteins: qualification of near‐ and far‐UV CD for protein higher order structural analysis

(2011) Cynthia H. Li et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Qualification of FTIR spectroscopic method for protein secondary structural analysis

(2011) Yijia Jiang et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Worldwide experience with biosimilar development

(2011) Mark McCamish et al.   mAbs

The use of ustekinumab in autoimmune disease

(2010) Caitriona Ryan et al.   EXPERT OPINION ON BIOLOGICAL THERAPY